Literature DB >> 8102599

Coexistence of functioning beta 1- and beta 2-adrenoceptors in single myocytes from human ventricle.

F del Monte1, A J Kaumann, P A Poole-Wilson, D G Wynne, J Pepper, S E Harding.   

Abstract

BACKGROUND: Both beta 1- and beta 2-adrenoceptors (beta 1 AR and beta 2 AR) are present in human ventricle. This study was designed to determine whether the two subtypes contribute to contraction in single myocytes from human heart. METHODS AND
RESULTS: (-)-Epinephrine increased the contraction amplitude and velocity of single myocytes isolated from the ventricles of failing and nonfailing human hearts. Concentration-response curves to (-)-epinephrine were constructed in the presence and absence of selective antagonists for beta 1 AR (CGP 20712A) and beta 2 AR (ICI 118,551). Responses to (-)-epinephrine were antagonized to a variable degree by the blockers, suggesting heterogeneous contribution of beta 1AR and beta 2AR among cells. The most common response in single myocytes was that ICI 118,551 (50 nmol/L) shifted the concentration-response curve less than 10-fold: this was lower than the 100-fold shift expected for a pure beta 2AR effect. Inclusion of CGP 20712A (300 nmol/L) with ICI 118,551 shifted the (-)-epinephrine curve still further. These observations suggest that both beta 1AR and beta 2AR contribute to the increase in contraction amplitude with (-)-epinephrine in this group of myocytes. When 300 nmol/L CGP 20712A was present as the sole antagonist, only a marginal shift of the concentration-response curve for (-)-epinephrine was usually observed, indicating that beta 1AR were not mediating the effect of these low concentrations of (-)-epinephrine. Both beta 1AR and beta 2AR mediated a considerable abbreviation of the time to peak contraction and time to 50% relaxation in the single cells.
CONCLUSIONS: beta 1AR and beta 2AR coexist and function on human ventricular myocytes. At low (-)-epinephrine concentrations, contractile responses are predominantly mediated by beta 2AR rather than beta 1AR in myocytes from failing hearts.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8102599     DOI: 10.1161/01.cir.88.3.854

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  23 in total

1.  Regulation of Abro1/KIAA0157 during myocardial infarction and cell death reveals a novel cardioprotective mechanism for Lys63-specific deubiquitination.

Authors:  Lucia Cilenti; Meenakshi P Balakrishnan; Xiao-Liang Wang; Camilla Ambivero; Martin Sterlicchi; Federica del Monte; Xin L Ma; Antonis S Zervos
Journal:  J Mol Cell Cardiol       Date:  2010-12-30       Impact factor: 5.000

2.  Targeted disruption of the mouse beta1-adrenergic receptor gene: developmental and cardiovascular effects.

Authors:  D K Rohrer; K H Desai; J R Jasper; M E Stevens; D P Regula; G S Barsh; D Bernstein; B K Kobilka
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

3.  Time-dependent evolution of functional vs. remodeling signaling in induced pluripotent stem cell-derived cardiomyocytes and induced maturation with biomechanical stimulation.

Authors:  Gwanghyun Jung; Giovanni Fajardo; Alexandre J S Ribeiro; Kristina Bezold Kooiker; Michael Coronado; Mingming Zhao; Dong-Qing Hu; Sushma Reddy; Kazuki Kodo; Krishna Sriram; Paul A Insel; Joseph C Wu; Beth L Pruitt; Daniel Bernstein
Journal:  FASEB J       Date:  2015-12-16       Impact factor: 5.191

4.  The coordinated increased expression of biliverdin reductase and heme oxygenase-2 promotes cardiomyocyte survival: a reductase-based peptide counters β-adrenergic receptor ligand-mediated cardiac dysfunction.

Authors:  Bo Ding; Peter E M Gibbs; Paul S Brookes; Mahin D Maines
Journal:  FASEB J       Date:  2010-09-27       Impact factor: 5.191

5.  Efficacy of beta 1-adrenergic receptors is lower than that of beta 2-adrenergic receptors.

Authors:  F O Levy; X Zhu; A J Kaumann; L Birnbaumer
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

6.  Studies on the intrinsic activity (efficacy) of human adrenergic receptors. Co-expression of beta 1 and beta 2 reveals a lower efficacy for the beta 1 receptor.

Authors:  L Birnbaumer; F O Levy; X Zhu; A J Kaumann
Journal:  Tex Heart Inst J       Date:  1994

7.  Selective beta1-adrenoceptor blockade enhances the activity of the stimulatory G-protein in human atrial myocardium.

Authors:  T Wang; C Plumpton; M J Brown
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

8.  Aβ Amyloid Pathology Affects the Hearts of Patients With Alzheimer's Disease: Mind the Heart.

Authors:  Luca Troncone; Marco Luciani; Matthew Coggins; Elissa H Wilker; Cheng-Ying Ho; Kari Elise Codispoti; Matthew P Frosch; Rakez Kayed; Federica Del Monte
Journal:  J Am Coll Cardiol       Date:  2016-12-06       Impact factor: 24.094

9.  Cardiostimulant and cardiodepressant effects through overexpressed human beta2-adrenoceptors in murine heart: regional differences and functional role of beta1-adrenoceptors.

Authors:  Jürgen F Heubach; Marianne Blaschke; Sian E Harding; Ursula Ravens; Alberto J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-03-04       Impact factor: 3.000

10.  Arrhythmogenic effects of beta2-adrenergic stimulation in the failing heart are attributable to enhanced sarcoplasmic reticulum Ca load.

Authors:  Jaime Desantiago; Xun Ai; Mohammed Islam; Georgia Acuna; Mark T Ziolo; Donald M Bers; Steven M Pogwizd
Journal:  Circ Res       Date:  2008-05-08       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.